Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda.
Elul B, Basinga P, Nuwagaba-Biribonwoha H, Saito S, Horowitz D, Nash D, Mugabo J, Mugisha V, Rugigana E, Nkunda R, Asiimwe A. Elul B, et al. Among authors: mugabo j. PLoS One. 2013;8(1):e53586. doi: 10.1371/journal.pone.0053586. Epub 2013 Jan 9. PLoS One. 2013. PMID: 23326462 Free PMC article.
Prevalence of kidney disease in HIV-infected and uninfected Rwandan women.
Wyatt CM, Shi Q, Novak JE, Hoover DR, Szczech L, Mugabo JS, Binagwaho A, Cohen M, Mutimura E, Anastos K. Wyatt CM, et al. Among authors: mugabo js. PLoS One. 2011 Mar 28;6(3):e18352. doi: 10.1371/journal.pone.0018352. PLoS One. 2011. PMID: 21464937 Free PMC article.
Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.
McNairy ML, Lamb MR, Carter RJ, Fayorsey R, Tene G, Mutabazi V, Gusmao E, Panya M, Sheriff M, Abrams EJ; Identifying Optimal Models of HIV Care and Treatment in Sub-Saharan Africa Consortium. McNairy ML, et al. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):e70-81. doi: 10.1097/QAI.0b013e318278bcb0. J Acquir Immune Defic Syndr. 2013. PMID: 23111575 Free PMC article.
Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda.
Ndahimana Jd, Riedel DJ, Mwumvaneza M, Sebuhoro D, Uwimbabazi JC, Kubwimana M, Mugabo J, Mulindabigwi A, Kirk C, Kanters S, Forrest JI, Jagodzinski LL, Peel SA, Ribakare M, Redfield RR, Nsanzimana S. Ndahimana Jd, et al. Among authors: mugabo j. Trop Med Int Health. 2016 Jul;21(7):928-35. doi: 10.1111/tmi.12717. Epub 2016 Jun 13. Trop Med Int Health. 2016. PMID: 27125473 Free article.
Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005.
Lowrance DW, Ndamage F, Kayirangwa E, Ndagije F, Lo W, Hoover DR, Hanson J, Elul B, Ayaba A, Ellerbrock T, Rukundo A, Shumbusho F, Nash D, Mugabo J, Assimwe A. Lowrance DW, et al. Among authors: mugabo j. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):49-55. doi: 10.1097/QAI.0b013e3181b03316. J Acquir Immune Defic Syndr. 2009. PMID: 19617847
Controlling hepatitis C in Rwanda: a framework for a national response.
Mbituyumuremyi A, Van Nuil JI, Umuhire J, Mugabo J, Mwumvaneza M, Makuza JD, Umutesi J, Nsanzimana S, Gupta N. Mbituyumuremyi A, et al. Among authors: mugabo j. Bull World Health Organ. 2018 Jan 1;96(1):51-58. doi: 10.2471/BLT.16.183772. Epub 2017 Nov 27. Bull World Health Organ. 2018. PMID: 29403100 Free PMC article.
12 results